telmisartan has been researched along with isoxazoles in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussar, DA | 1 |
| Cai, GY; Chen, XM; Duan, SW; Huang, W; Jia, Q; Li, JJ; Li, WG; Li, XM; Liu, SW; Liu, WH; Lun, LD; Ma, L; Sun, XF; Wang, YP; Wu, H; Wu, J; Xie, YS; Zhang, JR; Zhou, CH | 1 |
| Gu, Y; Körbel, C; Laschke, MW; Menger, MD; Nenicu, A | 1 |
| Emmerich, IU | 1 |
1 review(s) available for telmisartan and isoxazoles
| Article | Year |
|---|---|
[New drugs for small animals in 2018].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Antiparasitic Agents; Cats; Dexamethasone; Dogs; Ectoparasitic Infestations; Guinea Pigs; Injections; Isoxazoles; Meloxicam; Penicillin G Benzathine; Penicillin G Procaine; Platelet Aggregation Inhibitors; Sevoflurane; Solutions; Suspensions; Tablets; Telmisartan; Tramadol | 2019 |
1 trial(s) available for telmisartan and isoxazoles
| Article | Year |
|---|---|
Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial.
Topics: Adolescent; Adult; Benzimidazoles; Benzoates; Blood Pressure; China; Clopidogrel; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Isoxazoles; Kidney Function Tests; Leflunomide; Male; Middle Aged; Prospective Studies; Telmisartan; Ticlopidine; Treatment Outcome; Uric Acid; Young Adult | 2016 |
2 other study(ies) available for telmisartan and isoxazoles
| Article | Year |
|---|---|
New drugs 99, Part IV.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cefdinir; Cephalosporins; Citalopram; Drug Therapy; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Serotonin Receptor Agonists; Telmisartan; Tetrazoles; Triazoles; Tryptamines; United States; United States Food and Drug Administration | 1999 |
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caspase 3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Isoxazoles; Matrix Metalloproteinase 9; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-akt; Telmisartan; Ultrasonography | 2017 |